Dale Usner to Present at Duke-Industry Statistics Symposium ICH E9 (R1) at DISS 2020 Dale W. Usner, PhD, Chief Scientific Officer & Sr. Vice President, Strategic Scientific Consulting at SDC, will present “Considerations and Impact of Various Hypothetical...
Tempe, AZ, March 13, 2020 – SDC President and CEO Richard Abelson released the following statement regarding the Covid-19 pandemic: “Out of a concern for employees’ health and their families, as a result of Covid-19, SDC has moved to a ‘primarily’ work from home...
Dale W. Usner, Ph.D. , Co-Author of Article Published in Journal of Infectious Diseases Eleanor L. Ramos1, Jennifer L. Mitcham1, Teri D. Koller1, Aurelio Bonavia1, Dale W. Usner2, Ganesh Balaratnam3, Paul Fredlund1, and Kristine M. Swiderek1 Theraclone Sciences,...
Quan Doan, CCDM Presenting at SCDM 2014 Annual Conference Tempe, AZ, September 22, 2014 – Quan Doan, CCDM, Associate Director of EDC Solutions at SDC, will be presenting as an invited panelist during the Roundtable Session titled “Risk Based Monitoring: Drivers,...
Funds to Accelerate iMedNet™ EDC Sales, Marketing and R&D Initiatives Minnetonka, MN – MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that Arrowroot Capital, a growth equity...
Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomized, controlled study in patients with open-angle glaucoma or ocular hypertension Richard A. Lewis1, Brian Levy2, Nancy Ramirez2, Casey C. Kopczynski2, Dale W. Usner3, Gary D. Novack4...
